Adjuvant Therapy Reduces Fat Mass Loss during Exercise Prescription in Breast Cancer Survivors.
exercise prescription
lifestyle
oncology
physical activity
unsupervised exercise
Journal
Journal of functional morphology and kinesiology
ISSN: 2411-5142
Titre abrégé: J Funct Morphol Kinesiol
Pays: Switzerland
ID NLM: 101712257
Informations de publication
Date de publication:
15 Jul 2020
15 Jul 2020
Historique:
received:
26
05
2020
revised:
10
07
2020
accepted:
11
07
2020
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
21
1
2021
Statut:
epublish
Résumé
Improvements in cancer care over the years have increased the numbers of cancer survivors. Therefore, quality of life, fat mass management and physical activity are growing areas of interest in these people. After the surgical removal of a breast cancer, adjuvant therapy remains anyway a common strategy. The aim of this study was to assess how adjuvant therapy can affect the effectiveness of an unsupervised exercise program. Forty-two women were enrolled (52.0 ± 10.1 years). Assessments performed at baseline and after six months of exercise prescription were body composition, health-related quality of life, aerobic capacity by Six-Minute Walk Test, limbs strength by hand grip and chair test and flexibility by sit and reach. Statistical analyses were conducted by ANOVA tests and multiple regression. Improvements in body composition, physical fitness and quality of life (physical functioning, general health, social functioning and mental health items) were found. The percentage change in fat mass has been associated with adjuvant cancer therapy (intercept = -0.016; b = 8.629;
Identifiants
pubmed: 33467265
pii: jfmk5030049
doi: 10.3390/jfmk5030049
pmc: PMC7739281
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Curr Nutr Rep. 2014 Mar;3(1):9-15
pubmed: 24533234
Chest. 2001 Jan;119(1):256-70
pubmed: 11157613
Curr Opin Support Palliat Care. 2016 Dec;10(4):306-309
pubmed: 27684531
Asian J Sports Med. 2013 Dec;4(4):241-8
pubmed: 24799998
Am J Clin Nutr. 1996 Sep;64(3 Suppl):388S-396S
pubmed: 8780354
Med J Aust. 2003 Dec 1-15;179(11-12):580-5
pubmed: 14636121
Adv Exp Med Biol. 2017;960:571-606
pubmed: 28585217
J Sports Med Phys Fitness. 2019 May;59(5):846-852
pubmed: 30293406
J Appl Physiol (1985). 2005 Apr;98(4):1534-40
pubmed: 15772062
Support Care Cancer. 2018 Jul;26(7):2293-2301
pubmed: 29404842
Int J Sports Med. 2011 Jun;32(6):461-7
pubmed: 21380980
Cochrane Database Syst Rev. 2018 Jan 29;1:CD011292
pubmed: 29376559
Int J Sports Physiol Perform. 2019 Jun 8;14(7):994-996
pubmed: 30569764
J Clin Epidemiol. 1998 Nov;51(11):1025-36
pubmed: 9817120
World J Clin Oncol. 2014 May 10;5(2):177-90
pubmed: 24829866
Med Care. 2009 Jan;47(1):73-9
pubmed: 19106734
Lancet Oncol. 2009 Sep;10(9):865-71
pubmed: 19695956
J Clin Oncol. 2008 Feb 20;26(6):907-12
pubmed: 18281663
J Physiol. 2009 Dec 1;587(Pt 23):5559-68
pubmed: 19752112
J Sports Sci Med. 2014 Jan 20;13(1):1-14
pubmed: 24570599
J Am Coll Surg. 2013 Jun;216(6):1070-81
pubmed: 23523147
Brain Behav Immun. 2005 Sep;19(5):381-8
pubmed: 15922556
Int J Behav Nutr Phys Act. 2014 Sep 28;11:119
pubmed: 25260625
J Sports Med Phys Fitness. 2019 Feb;59(2):283-289
pubmed: 29498250
Health Qual Life Outcomes. 2009 Dec 23;7:102
pubmed: 20030832
Rev Bras Ginecol Obstet. 2014 Jun;36(6):244-50
pubmed: 25099463
Lancet Oncol. 2017 Aug;18(8):e457-e471
pubmed: 28759385
Qual Life Res. 2018 May;27(5):1237-1247
pubmed: 29417425
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):306-13
pubmed: 19124513
J Cancer Surviv. 2010 Jun;4(2):87-100
pubmed: 20052559
Curr Oncol Rep. 2016 Feb;18(2):12
pubmed: 26769117
Cancer Nurs. 2019 Mar/Apr;42(2):91-105
pubmed: 29649080
Cancer Nurs. 2020 Mar/Apr;43(2):115-125
pubmed: 30601270
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383